Showing results (71-80 of 172) with videos related to

Sort By:
Pageof 18
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 28, 2011
Phosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in ratsYvonne P de Visser, Frans J Walther, El Houari Laghmani, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 1, 2014
Sildenafil treatment in established right ventricular dysfunction improves diastolic function and attenuates interstitial fibrosis independent from afterloadMarinus A Borgdorff, Beatrijs Bartelds, Michael G Dickinson, et al.
The American Journal of Cardiology|August 6, 2002
Effectiveness of resynchronization therapy in patients with end-stage heart failureSander G Molhoek, Jeroen J Bax, Lieselot van Erven, et al.
Interactive Cardiovascular and Thoracic Surgery|April 24, 2012
Surgical left ventricular radius enlargement by patch insertion on the beating heart: a new experimental aneurysm modelPaul F Gründeman, Tycho I G van der Spoel, Paul Steendijk, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 8, 2013
Ambrisentan reduces pulmonary arterial hypertension but does not stimulate alveolar and vascular development in neonatal rats with hyperoxic lung injuryGerry T M Wagenaar, El Houari Laghmani, Yvonne P de Visser, et al.
Circulation|April 17, 2008
Role of left ventricular stiffness in heart failure with normal ejection fractionDirk Westermann, Mario Kasner, Paul Steendijk, et al.
Pathology, Research and Practice|October 5, 2007
Activation of signaling molecules and matrix metalloproteinases in right ventricular myocardium of rats with pulmonary hypertensionSoban Umar, Marleen Hessel, Paul Steendijk, et al.
The American Journal of Cardiology|June 28, 2005
Comparison of effectiveness of cardiac resynchronization therapy in patients with versus without diabetes mellitusPhilippine Kiès, Jeroen J Bax, Sander G Molhoek, et al.
The American Journal of Cardiology|March 31, 2004
Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathySander G Molhoek, Jeroen J Bax, Lieselot van Erven, et al.
Pageof 18